-
Share
28/08/15
06:11
Share
Sorry, the correct quote from that paragraph:
" preliminary studies suggest that Cantrixil is associated with cardiovascular toxicity though this observation is being assessed further. "
How does GK say in 2014, Cantrix is being manufactured for trials, and a year later, we hear preliminary studies?
Then the CEO just walks away ? Sorry, it all stinks and junior CEO's always think they can just walk from the train wrecks they create. Always.
Yes i'am ticked at a 70+% drop and a coded message to some, from the outgoing cheerleader.
-